CS
FRTX

Credit Suisse’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Credit Suisse’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4
Closed -$8K – 4539
2015
Q2 		$8K Buy
+4
New +$12.5K ﹤0.01% 4504
2014
Q4 		– Sell
-3
Closed -$12K – 4782
2014
Q3 		$12K Sell
3
-28
-90% -$109K ﹤0.01% 4404
2014
Q2 		$118K Buy
31
+15
+94% +$56.4K ﹤0.01% 4507
2014
Q1 		$64K Hold
16
– – ﹤0.01% 4560
2013
Q4 		$59K Sell
16
-34
-68% -$129K ﹤0.01% 4519
2013
Q3 		$198K Sell
50
-18
-26% -$135K ﹤0.01% 3969
2013
Q2 		$668K Buy
+68
New +$753K ﹤0.01% 3094

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Suisse's FRTX Position: Q3 2015 in Review

Credit Suisse sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 4 shares — an estimated $8K sold.

Credit Suisse first reported a position in FRTX in Q2 2013 and held it in 7 quarters. The position peaked at $668K in Q2 2013. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

  • Credit Suisse reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Credit Suisse sold 4 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $8K.
  • Credit Suisse first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
  • Credit Suisse's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $668K in Q2 2013.
  • 49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Credit Suisse's 13F filing for Q3 2015, filed 13 Nov 2015.